ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0956

Racial Disparities in Renal Outcomes over Time Among Hospitalized Children with SLE and Effects of Hospital Minority Composition

Joyce Chang1, Cora Sears2, Veronica Torres3 and Mary Beth Son1, 1Boston Children's Hospital, Brookline, MA, 2Children's Hospital of Philadelphia, Philadelphia, PA, 3Temple University, Bucks County, PA

Meeting: ACR Convergence 2021

Keywords: Disparities, Pediatric rheumatology, race/ethnicity, Renal, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 7, 2021

Title: Plenary II (0956–0961)

Session Type: Plenary Session

Session Time: 10:30AM-10:45AM

Background/Purpose: Racial and ethnic minorities are disproportionately affected by pediatric-onset SLE and have worse outcomes compared to their white counterparts. With ongoing advances in pediatric SLE care, it is not known how these gaps are changing. We determined whether changes in renal outcomes over time of hospitalized children with SLE varied by race/ethnicity, and whether these trends differed by hospital minority composition.

Methods: We identified patients ≤21 years old with an ICD-9/10 hospital discharge diagnosis of SLE in the Pediatric Health Information System® inpatient database from 2006-2019. Adverse renal outcomes were defined by assignment of an end-stage renal disease (ESRD) diagnosis code, dialysis procedure code, or renal transplant, analyzed separately and as a composite outcome. We used logistic regression models with fixed effects for time (calendar period), demographic and disease characteristics, and hospital-level random effects to estimate odds of a) an adverse renal outcome at any single hospital encounter or b) incident hospitalization for an adverse renal outcome, after which subsequent encounters were censored. We tested interactions between race and time to assess if change over time differed by race/ethnicity. Hospitals were further dichotomized by whether ≥50% of SLE patients were Black or ≥50% were Hispanic (Creanga et al. 2014) to test multiplicative interactions between hospital minority composition, race and time.

Results: There were 7,434 unique SLE patients with a total of 20,893 admissions at 50 hospitals. Racial/ethnic composition and patient characteristics are shown in Table 1. The proportion of SLE admissions with any adverse renal outcome, ESRD, or dialysis decreased over time from 2006 to 2019 (Fig. 1, p< 0.01 for trends). However, Black children remained significantly more likely to have an adverse renal outcome at any hospital encounter (adjusted OR 2.5, 95% CI [1.8-3.5]) over time compared to non-Hispanic whites. Black and Asian children were also more likely to have an incident hospitalization for an adverse renal outcome (OR 1.4 [1.1-1.8] and OR 1.5 [1.0-2.4], respectively). There were no significant changes in the magnitude of disparity over time. However, there were significant differences in both the magnitudes of disparities and changes in disparity levels over time between hospitals in which Black or Hispanic minorities comprised ≥50% of SLE patients vs. < 50% (p-values for interactions < 0.01). At hospitals with ≥50% Hispanic SLE patients, renal outcomes failed to improve at the same rate among Black and Hispanic white patients compared to non-Hispanic whites (Fig. 2A/B). At hospitals with ≥50% Black SLE patients, rates of renal outcomes improved less over time among black vs. non-Hispanic white children and worsened among Hispanic white children (Fig. 2C/D).

Conclusion: On average, adverse renal outcomes among hospitalized children with SLE decreased over a 13 year period, but racial disparities persisted without significant narrowing of the existing gap. There is a specific need to address greater or widening disparities that are systematically concentrated in local contexts despite population level improvements.

Figure 1. Proportion of SLE admissions in each calendar year that were assigned an ESRD diagnosis code, dialysis procedure code, or renal transplant procedure code, and composite outcome.

Figure 2. Marginal predictions of the average adjusted probability of adverse renal outcomes at any hospital encounter (composite of ESRD diagnosis, dialysis, renal transplant) over time by racial/ethnic category, stratified either by hospitals in which Hispanic patients comprise A) ≥50% of admitted SLE patients (N=7 hospitals) vs. B) <50% of SLE patients (N=43 hospitals), or by hospitals in which C) ≥50% of SLE patients are Black (N=18 hospitals) vs. D) <50% of SLE patients are Black (N=32 hospitals). All models are adjusted for age, census region, median household income, insurance type, APR-DRG severity of illness, and seizure.


Disclosures: J. Chang, GlaxoSmithKline, 5; C. Sears, None; V. Torres, None; M. Son, None.

To cite this abstract in AMA style:

Chang J, Sears C, Torres V, Son M. Racial Disparities in Renal Outcomes over Time Among Hospitalized Children with SLE and Effects of Hospital Minority Composition [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/racial-disparities-in-renal-outcomes-over-time-among-hospitalized-children-with-sle-and-effects-of-hospital-minority-composition/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/racial-disparities-in-renal-outcomes-over-time-among-hospitalized-children-with-sle-and-effects-of-hospital-minority-composition/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology